Thyrocare Technologies gains on making another equity investment in Thyrocare Laboratories
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Thyrocare Technologies is currently trading at Rs. 1027.10, up by 13.65 points or 1.35% from its previous closing of Rs. 1013.45 on the BSE.
The scrip opened at Rs. 1025.00 and has touched a high and low of Rs. 1050.65 and Rs. 1023.60 respectively. So far 4480 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1050.65 on 04-Dec-2024 and a 52 week low of Rs. 555.85 on 27-Mar-2024.
Last one week high and low of the scrip stood at Rs. 1050.65 and Rs. 959.65 respectively. The current market cap of the company is Rs. 5514.43 crore.
The promoters holding in the company stood at 71.11%, while Institutions and Non-Institutions held 16.73% and 12.16% respectively.
Thyrocare Technologies has made another tranche of equity investment of $100,000 (equivalent to Rs 84,90,000) in Thyrocare Laboratories (Tanzania) (Joint Venture Company). The equity infusion in the Joint Venture Company has been made to facilitate its business operations, including business expansion and working capital requirements.
The Joint Venture Company's business is similar to the Company’s main line of business viz. diagnostic and healthcare services.
Thyrocare Technologies is India's first and most advanced Totally Automated Laboratory having its strong presence in several cities / towns in India and internationally.
